CASI - CASI Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3-8.15%
S&P500 52-Week Change 325.98%
52 Week High 33.8300
52 Week Low 32.8300
50-Day Moving Average 33.1694
200-Day Moving Average 33.2250

Share Statistics

Avg Vol (3 month) 3103.37k
Avg Vol (10 day) 3159.28k
Shares Outstanding 596.35M
Float 37.32M
% Held by Insiders 146.96%
% Held by Institutions 120.37%
Shares Short (Dec 30, 2019) 42.99M
Short Ratio (Dec 30, 2019) 433.97
Short % of Float (Dec 30, 2019) 45.98%
Short % of Shares Outstanding (Dec 30, 2019) 43.10%
Shares Short (prior month Nov 28, 2019) 43.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jun 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,361.66%

Management Effectiveness

Return on Assets (ttm)-20.68%
Return on Equity (ttm)-39.55%

Income Statement

Revenue (ttm)2.79M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.73M
Net Income Avi to Common (ttm)-42.4M
Diluted EPS (ttm)-0.4440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)63.8M
Total Cash Per Share (mrq)0.66
Total Debt (mrq)2.43M
Total Debt/Equity (mrq)2.41
Current Ratio (mrq)10.56
Book Value Per Share (mrq)0.83

Cash Flow Statement

Operating Cash Flow (ttm)-33.57M
Levered Free Cash Flow (ttm)-29.96M